CClinicalTrials.gg
CompletedNCT04925245Updated Jun 14, 2021

Clinical Reminder to Improve Appropriateness of Echocardiography

An interventional study of Clinical Reminder in Echocardiography, sponsored by Stanford University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-06-14.

Sponsored by Stanford University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
1,365
Allocation
Randomized
Sex
All
01

Study summary

This study will test a clinical reminder to show recent echocardiograms when a new echocardiogram is ordered. The goal is to avoid unnecessary comprehensive echocardiography.

02

Conditions studied

  • Echocardiography
03

In context

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Echo ordered

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
1,365 participants (actual)

Study arms

  • Experimental
    Clinical Reminder

    Other: Clinical Reminder

  • No intervention
    No Reminder

Interventions

  • OtherClinical Reminder

    Clinical reminder in the electronic medical record

06

What researchers measure

Primary outcomes

  1. Comprehensive echo ordered

    Number of comprehensive echos completed

    Time frame: 24 hours from when when the initial order was placed

Secondary outcomes

  1. Cost of Echocardiography

    Cost of echocardiography during the hospital stay.

    Time frame: 30 days

07

Study locations

1 site
  • Stanford Health Care
    Stanford, California 94305, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04925245
Lead sponsor
Stanford University
Responsible party
Paul A. Heidenreich (Professor of Medicine, Stanford University) — Principal investigator
First posted
Jun 14, 2021
Start date
Sep 30, 2019
Primary completion
Apr 30, 2020
Completion
Dec 31, 2020
Last update
Jun 14, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion